AIMEE S WEISNER

CIK 1227308 · CVP, General Counsel · last filed 2026-06-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.35M

Companies

5

Total Filings

61

Lifetime Open-Market Net

-$4.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GKOS Director 22,684 $156.85 $3.56M -$4.67M 26 2026-06-23
LNSR Director 110,368 $5.20 $573.9K $131.3K 10 2026-06-05
STAA Director 15,352 $23.88 $366.5K $164.1K 7 2024-06-24
Oyster Point Pharma, Inc. (OYST) Delisted Director 3,573 $11.17 $39.9K $0 5 2023-01-04
EW CVP, General Counsel 10,050 $85.11 $855.3K $0 3 2012-05-11

Recent Filings · Page 4 of 7

61 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-06-06 GKOS Grant (A) +4,364 $0 EDGAR
2022-05-27 LNSR Grant (A) +4,285 $0 EDGAR
2022-01-05 GKOS Grant (A) +1,455 $0 EDGAR
2021-08-09 GKOS Grant (A) +2,000 $103.3K EDGAR
2021-06-09 Oyster Point Pharma, Inc. (OYST) Delisted Grant (A) +3,466 $0 EDGAR
2021-06-07 GKOS Grant (A) +2,382 $0 EDGAR
2021-05-20 LNSR Grant (A) $0 EDGAR
2021-03-16 LNSR Grant (A) $0 EDGAR
2021-02-02 LNSR Grant (A) $0 EDGAR
2021-01-06 GKOS Grant (A) +980 $0 EDGAR
Showing 3140 of 61
Page 4 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.